Rare disease patient organizations are coping with a broad range of other organizational challenges, including reduced funding, canceled fundraising events, sharp increases in requests for information and support from the patients they serve, and navigating the shift to remote work.


COVID-19 Impact on Rare Disease Clinical Trials

You may also be interested in: